v3.22.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 32,212,276 $ 40,750,133
Accounts receivable 6,552 110,141
Prepaid research and development 919,053 107,000
Prepaid expenses and other current assets 811,482 1,502,725
Total current assets 33,949,363 42,469,999
Equipment and improvements 43,089
Total assets 33,992,452 42,469,999
Current liabilities:    
Accounts payable 860,444 1,089,778
Accrued expenses and other current liabilities 3,629,861 2,715,761
Notes payable 0 248,911
Total liabilities 4,490,305 4,054,450
Commitments and contingencies (see Note 12)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2022, and December 31, 2021
Common stock, $0.001 par value; 100,000,000 shares authorized; 25,227,051 and 25,155,198 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively. 25,227 25,155
Additional paid-in capital 68,575,147 68,208,081
Accumulated deficit (39,098,227) (29,817,687)
Total 29,502,147 38,415,549
Total liabilities and stockholders' equity $ 33,992,452 $ 42,469,999

Source